Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Unemo

Showing results (391-400 of 438) with videos related to

Pageof 44
Sort By:
Journal of Clinical Microbiology|March 4, 2016
Genomic Epidemiology and Molecular Resistance Mechanisms of Azithromycin-Resistant Neisseria gonorrhoeae in Canada from 1997 to 2014Walter Demczuk, Irene Martin, Shelley Peterson, et al.
The Lancet. Infectious Diseases|July 6, 2020
Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysisDorothy A Machalek, Yusha Tao, Hannah Shilling, et al.
The Journal of Antimicrobial Chemotherapy|March 22, 2024
Recent dynamics in Neisseria gonorrhoeae genomic epidemiology in Brazil: antimicrobial resistance and genomic lineages in 2017-20 compared to 2015-16Daniel Golparian, Maria Luiza Bazzo, Josefine Ahlstrand, et al.
Msphere|September 12, 2022
Potent <i>In Vitro</i> and <i>Ex Vivo</i> Anti-Gonococcal Activity of the RpoB Inhibitor Corallopyronin AJennifer L Edwards, Jacqueline T Balthazar, Danillo L A Esposito, et al.
The Lancet. Microbe|June 3, 2026
Antimicrobial susceptibility patterns of Neisseria gonorrhoeae across anatomical sites within and between individuals in the Netherlands: a retrospective observational studyMaartje Visser, Petra F G Wolffs, Christian J P A Hoebe, et al.
Vaccine|May 4, 2020
Gonococcal vaccines: Public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019Sami L Gottlieb, Francis Ndowa, Edward W Hook, et al.
Plos One|October 11, 2019
Antimicrobial resistance (AMR) and molecular characterization of Neisseria gonorrhoeae in Ghana, 2012-2015Naiki Attram, Bright Agbodzi, Helena Dela, et al.
BMC Global and Public Health|December 16, 2024
Recommendations for the optimal introduction of novel antibiotics to treat uncomplicated gonorrhoea in the face of increasing antimicrobial resistance: a case study with zoliflodacinFernando Pascual, Carmen Au, Chido Dziva Chikwari, et al.
Jac-Antimicrobial Resistance|February 2, 2024
Antimicrobial susceptibility in <i>Neisseria gonorrhoeae</i> and epidemiological data of gonorrhoea patients in five cities across Ethiopia, 2021-22Muluken Birhanu, Woldaregay Erku Abegaz, Daniel Schröder, et al.
Acta Dermato-Venereologica|March 4, 2011
Survey of diagnostic services for genital herpes in fourteen countries in Eastern EuropeMarius Domeika, Karen Babayan, Rashad Ismailov, et al.
Pageof 44

Showing results (391-400 of 438) with videos related to

Sort By:
Pageof 44
Journal of Clinical Microbiology|March 4, 2016
Genomic Epidemiology and Molecular Resistance Mechanisms of Azithromycin-Resistant Neisseria gonorrhoeae in Canada from 1997 to 2014Walter Demczuk, Irene Martin, Shelley Peterson, et al.
The Lancet. Infectious Diseases|July 6, 2020
Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysisDorothy A Machalek, Yusha Tao, Hannah Shilling, et al.
The Journal of Antimicrobial Chemotherapy|March 22, 2024
Recent dynamics in Neisseria gonorrhoeae genomic epidemiology in Brazil: antimicrobial resistance and genomic lineages in 2017-20 compared to 2015-16Daniel Golparian, Maria Luiza Bazzo, Josefine Ahlstrand, et al.
Msphere|September 12, 2022
Potent <i>In Vitro</i> and <i>Ex Vivo</i> Anti-Gonococcal Activity of the RpoB Inhibitor Corallopyronin AJennifer L Edwards, Jacqueline T Balthazar, Danillo L A Esposito, et al.
The Lancet. Microbe|June 3, 2026
Antimicrobial susceptibility patterns of Neisseria gonorrhoeae across anatomical sites within and between individuals in the Netherlands: a retrospective observational studyMaartje Visser, Petra F G Wolffs, Christian J P A Hoebe, et al.
Vaccine|May 4, 2020
Gonococcal vaccines: Public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019Sami L Gottlieb, Francis Ndowa, Edward W Hook, et al.
Plos One|October 11, 2019
Antimicrobial resistance (AMR) and molecular characterization of Neisseria gonorrhoeae in Ghana, 2012-2015Naiki Attram, Bright Agbodzi, Helena Dela, et al.
BMC Global and Public Health|December 16, 2024
Recommendations for the optimal introduction of novel antibiotics to treat uncomplicated gonorrhoea in the face of increasing antimicrobial resistance: a case study with zoliflodacinFernando Pascual, Carmen Au, Chido Dziva Chikwari, et al.
Jac-Antimicrobial Resistance|February 2, 2024
Antimicrobial susceptibility in <i>Neisseria gonorrhoeae</i> and epidemiological data of gonorrhoea patients in five cities across Ethiopia, 2021-22Muluken Birhanu, Woldaregay Erku Abegaz, Daniel Schröder, et al.
Acta Dermato-Venereologica|March 4, 2011
Survey of diagnostic services for genital herpes in fourteen countries in Eastern EuropeMarius Domeika, Karen Babayan, Rashad Ismailov, et al.
Pageof 44